Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-01
1998-03-17
Marschel, Ardin H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 691, 4351723, 514 8, 530300, 530350, A61K 3816, A61K 3817, A61K 3836
Patent
active
057286744
ABSTRACT:
The present invention provides isolated DNA molecules comprising a DNA segment encoding novel human Kunitz-type inhibitors. Also provided are DNA constructs comprising a first DNA segment encoding a novel human Kunitz-type inhibitor wherein said first DNA segment is operably linked to additional DNA segments required for the expression for the first DNA segment, as well as host cells containing such DNA constructs and methods for producing proteins from the host cells.
REFERENCES:
patent: 4736018 (1988-04-01), Reutelingsperger
patent: 5106833 (1992-04-01), Broze, Jr. et al.
patent: 5276015 (1994-01-01), Khouri et al.
patent: 5312736 (1994-05-01), Rasmusson et al.
Sprecher et al., Proc. Natl. Acad. Sci. U.S.A. 91:3353-3357, 1994.
Kisiel, Blood 84(12): 4384, 1994.
Miyagi et al., J. Biochem. 116: 939-942, 1994.
Day et al., Thrombosis Research 68: 369-381, 1992.
Girard et al., Nature 338: 518-520, 1989.
Hamamoto et al., J. Biol. Chem. 268(2): 8704-8710, 1993.
Enjyoji et al., J. Biochem. 111: 681-687, 1992.
Broze, Jr., et al. Biochemistry 29(33): 7539-7546, 1990.
Wun et al., J. Biol. Chem. 263(13): 6001-6004, 1988.
Broze, Jr., et al., Blood 71(2): 335-343, 1988.
Pedersen et al., J. Biol. 265(28): 16786-16793, 1990.
Warn-Cramer et al., Circulation 74(Supp II) Abstract No. 1630: II-408, 1986.
Norris et al., Biol., Chem. Hoppe-Seyler 371: 37-42, 1990.
Nordfang et al., Biochemistry 30: 10371-10376, 1991.
Wesselschmidt et al., Blood 79(8): 2004-2010, 1992.
Girard et al., Science 248: 1421-1424, 1990.
Sanders, et al., Blood 66(1): 204-212, 1985.
Broze, Jr., et al., Proc. Natl. Acad. Sci. U.S.A. 84: 1886-1890, 1987.
Warn-Cramer et al., Thrombosis and Haemostasis 60(3): 453-456, 1988.
Wesselschmidt et al., Nucleic Acids Research 18(21): 6440, 1990.
Day et al., Blood 76(8): 1538-1545, 1990.
Neuenschwander et al., J. Biol. Chem. 267(20): 14477-14482, 1992.
Broze et al., Blood 69(1): 150-155, 1987.
Adams et al., Nature 355: 632-634, 1992.
Laskowski et al., Ann. Rev. Biochem. 49: 593-626, 1980.
Creighton et al., J. Mol. Biol. 194: 11-22, 1987.
Butzow et al., Biochemical and Biophysical Communications 150(1): 483-490, 1988.
Foster Donald C.
Kisiel Walt
Sprecher Cindy A.
Lingenfelter Susan E.
Marschel Ardin H.
ZymoGenetics Inc.
LandOfFree
Inhibition of blood coagulation by human-kunitz-type inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of blood coagulation by human-kunitz-type inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of blood coagulation by human-kunitz-type inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-957591